CXCR4 and non-small cell lung carcinoma: Zhou et al. conducted a meta-analysis of 1,446 NSCLC patients across 13 investigations, finding that CXCR4 expression was significantly associated with advanced-stage disease, metastasis, and reduced survival, reinforcing its role as a prognostic marker (Zhou et al., 2015).